藏药三果汤防治高原红细胞增多症的临床疗效评价
|
摘要
目的探讨藏药三果汤防治高原红细胞增多症的临床疗效。方法于本院2017年3月至2018年3月接收的高原红细胞增多症患者中选取64例,随机分为观察组(32例)与对照组(32例)。对照组接受放血治疗联合吸氧治疗,在此基础上观察组增加接受藏药三果汤治疗。对比临床疗效,并观察治疗前后血红蛋白(Hb)、红细胞计数(RBC)、红细胞压积(HCT)水平。结果观察组治疗总有效率较对照组更高,P<0.05。两组治疗前Hb、RBC、HCT水平比较P>0.05。观察组治疗后Hb、RBC、HCT水平较对照组与治疗前均显著降低,P<0.05。结论高原红细胞增多症在接受常规治疗的基础上加以藏药三果汤治疗效果更为理想,可有效改善患者血液学指标水平,缓解患者临床症状,实用价值较高,值得推广。
Objective To investigate the clinical efficacy of Tibetan medicine Sanguo Decoction in preventing and treating high altitude polycythemia. Methods Sixty-four patients with high altitude polycythemia who were admitted to our hospital from March 2017 to March 2018 were randomLy divided into observation group(32 cases) and control group(32 cases). The control group received bloodletting treatment combined with oxygen therapy. On this basis, the observation group increased the treatment of Tibetan medicine Sanguo Decoction. The clinical efficacy was compared and the levels of hemoglobin(Hb), red blood cell count(RBC) and hematocrit(HCT) were observed before and after treatment. Results The total effective rate of the observation group was higher than that of the control group, P<0.05.The levels of Hb, RBC and HCT before treatment were compared in the two groups(P>0.05). The levels of Hb, RBC and HCT in the observation group were significantly lower than those in the control group and before treatment, P<0.05.Conclusion Plateau polycythemia is more ideal for the treatment of Tibetan medicine Sanguo Decoction on the basis of conventional treatment. It can effectively improve the blood level of patients, relieve the clinical symptoms of patients,and has high practical value. It is worth promoting.
Objective To investigate the clinical efficacy of Tibetan medicine Sanguo Decoction in preventing and treating high altitude polycythemia. Methods Sixty-four patients with high altitude polycythemia who were admitted to our hospital from March 2017 to March 2018 were randomLy divided into observation group(32 cases) and control group(32 cases). The control group received bloodletting treatment combined with oxygen therapy. On this basis, the observation group increased the treatment of Tibetan medicine Sanguo Decoction. The clinical efficacy was compared and the levels of hemoglobin(Hb), red blood cell count(RBC) and hematocrit(HCT) were observed before and after treatment. Results The total effective rate of the observation group was higher than that of the control group, P<0.05.The levels of Hb, RBC and HCT before treatment were compared in the two groups(P>0.05). The levels of Hb, RBC and HCT in the observation group were significantly lower than those in the control group and before treatment, P<0.05.Conclusion Plateau polycythemia is more ideal for the treatment of Tibetan medicine Sanguo Decoction on the basis of conventional treatment. It can effectively improve the blood level of patients, relieve the clinical symptoms of patients,and has high practical value. It is worth promoting.
引文
[1]王曙光,李继志.高原红细胞增多症发病高危因素及其治疗的研究进展[J].临床合理用药杂志,2016,9(30):178-180.
[2]德吉,侯永志,李震宇.组织多普勒Tei指数评价高原红细胞增多症患者右心室功能的意义[J].中国现代医药杂志,2017,19(2):79-80.
[3]刘芳,魏巍,冀林华.高原红细胞增多症模型大鼠骨髓CD71+细胞GATA-1和GATA-2表达的相关性[J].中国病理生理杂志,2016,32(10):1863-1869.
[4]王晓.腹腔镜下胆囊切除术合并高原红细胞增多症267例临床分析[J].心理医生,2016,22(27):120-121.
[5]赵一多,张致英,刘丽军.中国藏族人群高原红细胞增多症与KDM5B、LAMB3基因多态性之间的关联(英文)[J].中国高原医学与生物学杂志,2017,38(1):3-9.
[6]陈清振,李占全.促红细胞生成素及睾酮与高原红细胞增多症关系的研究进展[J].中华医学杂志,2016,96(2):158-160.
[7]高亮,李彬,李年华.驻海拔5000m以上高原红细胞增多症患者血清炎症因子变化分析[J].人民军医,2018,61(5):49-51,55.
[8]李晓娜,任海林,于梅花.高原红细胞增多症患者雄激素受体基因多态性检测[J].环境与健康杂志,2017,34(9):812-814.
[9]邓全军,米玛拉姆,扎西措姆.高原红细胞增多症合并消化性溃疡病临床分析[J].中华实用诊断与治疗杂志,2017,31(2):167-169.
[10]仁青东智.藏药结合放血疗法治疗高原红细胞增多症114例疗效观察[J].中国民族医药杂志,2016,22(7):5-6.
[2]德吉,侯永志,李震宇.组织多普勒Tei指数评价高原红细胞增多症患者右心室功能的意义[J].中国现代医药杂志,2017,19(2):79-80.
[3]刘芳,魏巍,冀林华.高原红细胞增多症模型大鼠骨髓CD71+细胞GATA-1和GATA-2表达的相关性[J].中国病理生理杂志,2016,32(10):1863-1869.
[4]王晓.腹腔镜下胆囊切除术合并高原红细胞增多症267例临床分析[J].心理医生,2016,22(27):120-121.
[5]赵一多,张致英,刘丽军.中国藏族人群高原红细胞增多症与KDM5B、LAMB3基因多态性之间的关联(英文)[J].中国高原医学与生物学杂志,2017,38(1):3-9.
[6]陈清振,李占全.促红细胞生成素及睾酮与高原红细胞增多症关系的研究进展[J].中华医学杂志,2016,96(2):158-160.
[7]高亮,李彬,李年华.驻海拔5000m以上高原红细胞增多症患者血清炎症因子变化分析[J].人民军医,2018,61(5):49-51,55.
[8]李晓娜,任海林,于梅花.高原红细胞增多症患者雄激素受体基因多态性检测[J].环境与健康杂志,2017,34(9):812-814.
[9]邓全军,米玛拉姆,扎西措姆.高原红细胞增多症合并消化性溃疡病临床分析[J].中华实用诊断与治疗杂志,2017,31(2):167-169.
[10]仁青东智.藏药结合放血疗法治疗高原红细胞增多症114例疗效观察[J].中国民族医药杂志,2016,22(7):5-6.